Correlation Between Skyline Investment and Medicofarma Biotech

Can any of the company-specific risk be diversified away by investing in both Skyline Investment and Medicofarma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Skyline Investment and Medicofarma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Skyline Investment SA and Medicofarma Biotech SA, you can compare the effects of market volatilities on Skyline Investment and Medicofarma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Skyline Investment with a short position of Medicofarma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Skyline Investment and Medicofarma Biotech.

Diversification Opportunities for Skyline Investment and Medicofarma Biotech

0.05

Correlation Coefficient

Skyline Investment  Medicofarma Biotech

Significant diversification

The 3 months correlation between Skyline and Medicofarma is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Skyline Investment SA and Medicofarma Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicofarma Biotech and Skyline Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Skyline Investment SA are associated (or correlated) with Medicofarma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicofarma Biotech has no effect on the direction of Skyline Investment i.e., Skyline Investment and Medicofarma Biotech go up and down completely randomly.

Pair Corralation between Skyline Investment and Medicofarma Biotech

Assuming the 90 days trading horizon Skyline Investment is expected to generate 2.65 times less return on investment than Medicofarma Biotech. But when comparing it to its historical volatility, Skyline Investment SA is 2.28 times less risky than Medicofarma Biotech. It trades about 0.16 of its potential returns per unit of risk. Medicofarma Biotech SA is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  36.00  in Medicofarma Biotech SA on October 23, 2024 and sell it today you would earn a total of  3.00  from holding Medicofarma Biotech SA or generate 8.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Skyline Investment SA  vs.  Medicofarma Biotech SA

Skyline Investment

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Skyline Investment SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Skyline Investment is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Medicofarma Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Skyline Investment and Medicofarma Biotech

The main advantage of trading using opposite Skyline Investment and Medicofarma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Skyline Investment position performs unexpectedly, Medicofarma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicofarma Biotech will offset losses from the drop in Medicofarma Biotech's long position.

The idea behind Skyline Investment SA and Medicofarma Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.